We are live on ! Find out more
RCKT icon

Rocket Pharmaceuticals
RCKT

173 hedge funds and large institutions have $315M invested in Rocket Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 61 increasing their positions, 62 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

98% more call options, than puts

Call options by funds: $2.87M | Put options by funds: $1.45M

35% more capital invested

Capital invested by funds: $233M → $315M (+$81.8M)

0.53% more ownership

Funds ownership: 88.98% → 89.52% (+0.53%)

2% less repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 62

12% less funds holding

Funds holding: 196 → 173 (-23)

44% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 50

Holders
173
Holders Change
-23
Holders Change %
-11.73%
% of All Funds
2.27%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
28
Increased
61
Reduced
62
Closed
50
Calls
$2.87M
Puts
$1.45M
Net Calls
+$1.42M
Net Calls Change
+$925K

Top Buyers

1
MAM
Monaco Asset Management
Monaco
+$7.68M
2
Citadel Advisors
Citadel Advisors
Florida
+$4.77M
3
Millennium Management
Millennium Management
New York
+$3.85M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$3.77M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$3.72M

Top Sellers

1
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
-$2.69M
2
CSS
Cubist Systematic Strategies
Connecticut
-$1.76M
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$1.68M
4
WP
Woodline Partners
California
-$1.6M
5
N
Nuveen
North Carolina
-$1.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
UB
151
UMB Bank
Missouri
$6.67K +$6.44K +2,046 New
AF
152
Allworth Financial
California
$6.59K +$4.35K +1,381 +216%
Jones Financial Companies
153
Jones Financial Companies
Missouri
$6.11K -$472 -150 -7%
Nisa Investment Advisors
154
Nisa Investment Advisors
Missouri
$5.32K +$372 +118 +8%
Comerica Bank
155
Comerica Bank
Texas
$4.43K +$3.37K +1,070 +372%
PWA
156
Physician Wealth Advisors
Utah
$3.79K +$2.12K +672 +137%
Optiver Holding
157
Optiver Holding
Netherlands
$3.52K +$3.4K +1,080 New
ASN
158
Advisory Services Network
Georgia
$3.26K +$3.15K +1,000 New
US Bancorp
159
US Bancorp
Minnesota
$3.09K -$2.04K -649 -41%
CA
160
Clearstead Advisors
Ohio
$2.37K +$2.29K +726 New
NA
161
NewEdge Advisors
Louisiana
$2.28K – – –
IA
162
IFP Advisors
Florida
$2.1K -$123 -39 -6%
MPWT
163
MassMutual Private Wealth & Trust
Connecticut
$2.04K +$580 +184 +42%
Daiwa Securities Group
164
Daiwa Securities Group
Japan
$1K – – –
PA
165
Parallel Advisors
California
$910 +$154 +49 +21%
SS
166
SBI Securities
Japan
$766 -$35 -11 -4%
TWD
167
True Wealth Design
Ohio
$685 +$661 +210 New
LFG
168
Larson Financial Group
Missouri
$473 +$69 +22 +18%
MCM
169
MAI Capital Management
Ohio
$333 -$252 -80 -44%
PS
170
Principal Securities
Iowa
$137 +$132 +42 New
SS
171
Sunbelt Securities
Texas
$101 +$98 +31 New
WANY
172
Wealthspire Advisors (New York)
New York
$66 +$63 +20 New
Toronto Dominion Bank
173
Toronto Dominion Bank
Ontario, Canada
– -$2.69M -1,100,000 Closed
CSS
174
Cubist Systematic Strategies
Connecticut
– -$1.76M -718,781 Closed
WP
175
Woodline Partners
California
– -$1.6M -652,865 Closed
5 6
7
8 9

RCKT Hedge Fund Activity: Q3 2025 in Review

173 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals (RCKT) for Q3 2025, worth a combined $315M — up 35% from $233M a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of RCKT and 28 opened new positions — a net loss of 22 holders — while 62 trimmed existing stakes and 61 added.

The largest buyer was Monaco Asset Management, adding an estimated $7.68M. The largest seller was Toronto Dominion Bank, exiting entirely with an estimated $2.69M sold.

  • 173 institutional investors held Rocket Pharmaceuticals (RCKT) as of Q3 2025, down from 196 in Q2 2025.
  • Funds reported $315M of Rocket Pharmaceuticals stock for Q3 2025, up 35% quarter-over-quarter.
  • 28 funds opened new Rocket Pharmaceuticals positions in Q3 2025 and 50 closed out, a net change of -22 holders.
  • The largest Rocket Pharmaceuticals buyer in Q3 2025 was Monaco Asset Management, an estimated $7.68M added.
  • The largest Rocket Pharmaceuticals seller in Q3 2025 was Toronto Dominion Bank, an estimated $2.69M sold.

Based on aggregated 13F filings for Q3 2025.